Did You Know?

Editor’s Picks

Latest News

PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections

Top-line Data Anticipated by Year End 2021 Enrollment Also Continues to Progress in Company’s Second Phase 3 Clinical Trial, SHIELD...

Monopar Announces First Patient Dosed in its Phase 2b/3 VOICE Trial Evaluating Validive® for the Prevention of Chemoradiotherapy-Induced Severe Oral Mucositis (SOM) in Oropharyngeal Cancer (OPC)

There are currently no FDA-approved drugs to prevent or treat chemoradiotherapy-induced SOMWILMETTE, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Monopar...

OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing

Study highlights best practice techniques for accurate antimicrobial resistance prediction from whole-genome sequencing data Publication supports harmonization of the development...

OmniSYS Scales IT Capacity with Virtustream Enterprise Cloud to Meet Record-Setting Demands of U.S. Pharmacies Managing COVID-19 Vaccines

MCLEAN, Va.--(BUSINESS WIRE)--Virtustream, an enterprise-class cloud company and a Dell Technologies business, announced today that OmniSYS, a Dallas-based healthcare technology...

error: Content is protected !!